Information processing system and program

Abstract

To relate to an information processing system for introducing a qualified pharmaceutical sales person suitable for a user having skin trouble symptoms in a schedule desired by the user to the user.SOLUTION: An information processing system is provided with a processing part. The processing part acquires skin information including symptom information showing user's skin trouble symptoms and desired schedule information showing a user's desired schedule in which the user discusses the skin trouble symptoms with qualified pharmaceutical sales persons, acquires available schedule information of each of a plurality of qualified pharmaceutical sales persons and available skin trouble symptom information about available skin trouble symptoms of each of the plurality of qualified pharmaceutical sales persons which are prepared in advance, and extracts an available qualified pharmaceutical sales person to the user's skin trouble symptoms included in the symptom information in a desired schedule included in the desired schedule information as the qualified pharmaceutical sales person to be introduced to the user from among the plurality of qualified pharmaceutical sales persons on the basis of the available schedule information and the available skin trouble symptom information.SELECTED DRAWING: Figure 3

Description

[Technical field]

[0001] The present technology relates to an information processing system and program that introduces qualified pharmaceutical sales personnel suitable for users with skin problems. [Background technology]

[0002] For example, users with skin problems are likely to feel psychological stress due to various physical symptoms such as skin inflammation, dryness, and darkening, and may be forced to restrict their activities in daily life. For example, due to skin symptoms, users may feel stressed about exposing their skin, not want to talk to people, lose sleep due to itching, unconsciously scratch their skin and soil their bedding, symptoms may worsen or pain may occur due to work that requires excessive disinfection or water work, and users may hesitate to have physical contact with their children, and skin diseases can easily impair the quality of life.

[0003] For example, Patent Document 1 describes that a patient terminal specifies the name of a chronic disease and applies for remote medical treatment and medication instructions, and a management device grants a doctor or pharmacy access rights to information such as patient information. [Prior art documents] [Patent documents]

[0004] [Patent Document 1] JP 2021-177306 A Summary of the Invention [Problem to be solved by the invention]

[0005] In treating skin troubles, users may find it difficult to select a method of care suitable for their symptoms, and may feel unsure whether the method they are using is correct. For this reason, it is desirable to provide users with skin troubles with accurate advice on skin care methods on a schedule of their choice.

[0006] The present invention relates to an information processing system and a program for introducing a qualified pharmaceutical salesperson suitable for a user having skin trouble symptoms to the user on a schedule desired by the user. [Means for solving the problem]

[0007] An information processing system according to an embodiment of the present invention includes a processing unit. The processing unit includes: Acquire skin information including symptom information indicating a skin trouble symptom of a user and desired schedule information indicating a desired schedule of the user for the user to consult with a pharmaceutical sales qualified person about the skin trouble symptom; Acquire previously prepared schedule information on the availability of each of a plurality of drug sales qualified persons and available skin trouble symptom information regarding the available skin trouble symptoms that each of the plurality of drug sales qualified persons can treat, Based on the available schedule information and the available skin trouble symptom information, a qualified pharmaceutical salesperson who can treat the user's skin trouble symptom included in the symptom information on the desired schedule included in the desired schedule information is extracted from the multiple qualified pharmaceutical salespersons as a qualified pharmaceutical salesperson to be introduced to the user.

[0008] A program according to one embodiment of the present invention comprises: In the information processing device, acquiring skin information including symptom information indicating a skin trouble symptom of a user and desired schedule information indicating a desired schedule of the user for the user to consult with a pharmaceutical sales qualified person about the skin trouble symptom; A step of acquiring previously prepared schedule information of each of a plurality of drug sales qualified persons and information on skin trouble symptoms that each of the plurality of drug sales qualified persons can treat; A step of extracting, from among the plurality of qualified pharmaceutical sales persons, a qualified pharmaceutical sales person capable of dealing with the skin trouble symptom of the user included in the symptom information on the desired schedule included in the desired schedule information, as a qualified pharmaceutical sales person to be introduced to the user, based on the available schedule information and the available skin trouble symptom information. Execute the command. Effect of the Invention

[0009] According to the present invention, a qualified pharmaceutical salesperson suitable for a user having skin trouble symptoms can be introduced to the user on a schedule desired by the user. [Brief description of the drawings]

[0010] [Figure 1] 1 is a diagram illustrating services provided by an information processing system according to one embodiment of the present invention to users with skin problems and pharmacists. [Diagram 2] FIG. 2 is a hardware configuration diagram of a server (information processing device) that provides various services related to a skin care program of the information processing system. [Diagram 3] FIG. 2 is a block diagram showing a functional configuration of the information processing system. [Figure 4] FIG. 1 is a diagram (part 1) showing an example of information stored in a care method DB (database) included in the information processing system. [Diagram 5] FIG. 2 is a diagram (part 2) showing an example of information stored in a care method DB included in the information processing system. [Figure 6] 13 is an example of a questionnaire image for obtaining pharmacist information, which is displayed on the display unit of a pharmacy terminal included in the information processing system. [Figure 7] 3 is a diagram showing an example of pharmacist information stored in a pharmacist information DB included in the information processing system. FIG. [Figure 8] 4 is a flow diagram of an information processing method for acquiring pharmacist information in the above information processing system. [Figure 9]13 is a first example of a questionnaire image for acquiring user information, which is displayed on a display unit of a user terminal included in the information processing system. [Figure 10] 13 is a second example of a questionnaire image for acquiring user information, which is displayed on a display unit of a user terminal included in the information processing system. [Figure 11] 13 is an example of a care method image displayed on a display unit of a user terminal, showing a care method determined by the information processing system. [Figure 12] 13 is an example of a care method image displayed on a display unit of a user terminal, showing a care method determined by the information processing system. [Figure 13] 13 is a flow diagram of an information processing method for determining a pharmacist who will be a consultation partner for a user in the above information processing system. [Figure 14] 13 is an example of an image displayed on a display unit of a user terminal when a skin image of a user is acquired in the information processing system. [Figure 15] FIG. 14 is a flow diagram (part 1) of the pharmacist provisional decision process in the flow shown in FIG. 13. [Figure 16] FIG. 14 is a flow diagram (part 2) of the pharmacist provisional decision process in the flow shown in FIG. 13. [Figure 17] This is a flow diagram (part 3) of the pharmacist provisional decision process in the flow shown in Figure 13. [Figure 18] FIG. 4 is a flow diagram of an information processing method during monitoring processing in the information processing system. [Figure 19] 13 is an example of a monitoring image displayed on the display unit of the user terminal during third monitoring in the information processing system. [Figure 20] This is an example of a questionnaire image showing questions regarding consultation with a pharmacist, which is displayed on the display unit of a user terminal during the second or subsequent monitoring process in the above information processing system. [Figure 21] FIG. 11 is a block diagram showing a functional configuration of an information processing system according to another embodiment. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0011] The present invention will be described below with reference to the drawings. The present invention is not limited to the embodiments shown below, and various modifications can be made without departing from the scope of the present invention. In the following description, the same reference numerals are used for the configurations already described, and the description may be omitted. In addition, in the description of the information processing method, the same step numbers are used for the steps already described, and the description may be omitted.

[0012] <Information Processing System> An information processing system according to the present invention will be described with reference to FIG. 1. In the information processing system 100, a user with skin trouble symptoms is introduced to a qualified pharmaceutical salesperson suitable for the user on a date desired by the user. In this embodiment, an example is given in which a service is provided to introduce a qualified pharmaceutical salesperson to a user who uses a skin care program provided by a skin care program providing service provider. A qualified pharmaceutical salesperson has specialized knowledge of pharmaceuticals, and specifically, is a pharmacist, a doctor, a registered salesperson, a nurse who assists a doctor in medical treatment, etc., and is typically a pharmacist. The following description will be given taking a pharmacist as an example.

[0013] As shown in FIG. 1, information processing system 100 includes a skin care program providing server (hereinafter simply referred to as "server") 10, a plurality of user terminals 1 (1A-1C...), and a plurality of pharmacy terminals 20 (20a-20c...). Server 10 and user terminals 1, and server 10 and pharmacy terminals 20 are connected via Internet 50. Server 10 provides service S1 to user U (U1-U3...) who uses the skin care program. Server 10 provides service S2 to pharmacist P (P1-P5...) who is introduced to user U and is available for face-to-face consultation with user U. Pharmacy terminal 20 is installed, for example, in the pharmacy to which the pharmacist belongs.

[0014] 1, in the information processing system 100, various services S1 can be provided to each of a plurality of users U who have skin trouble symptoms and have applied to use the skin care program by a server 10 serving as an information processing device used for operation by a skin care program providing service provider. The services S1 include a pharmacist introduction service 96, a schedule adjustment service 97, a care method suggestion service 98, a monitoring service 99, and the like.

[0015] In the information processing system 100, a plurality of pharmacists who can give appropriate advice to the user when implementing a skin care program are registered. In the information processing system 100, various services S2 can be provided to the pharmacist P by the server 10. The services S2 include a user information providing service 85 that provides information related to the user who wishes to consult, a schedule adjustment service 86, a care method suggestion service 87, a monitoring information providing service 88, and the like.

[0016] In this specification, "care" includes treatment, treatment, etc. When the user carries out the care method suggested in the skin care program, the user's skin trouble symptoms can be improved.

[0017] The information processing system 100 of this embodiment provides a skin care method for a user with skin trouble symptoms, the execution period of which is set to a predetermined length in advance. In this embodiment, the execution period of the skin care method is, for example, about 28 days, which is the skin turnover cycle, but is not limited to this length. In this way, by setting the execution period of the skin care method to match the skin turnover cycle or to a length longer than that, it is easy to realize the effect of executing the skin care method. In addition, by setting the execution period of the skin care method, the time goal for executing the skin care method becomes clear, making it easier for the user to continue the care. It is not necessary to set the execution period of the skin care method.

[0018] Skin trouble symptoms include eczema (bumps), redness, itchiness, cracked / chapped skin, darkening, roughness / stiffness / flaking / peeling, acne / pimples, and scars.

[0019] The "care method" proposed to the user is a method of caring for the symptom manifestation site where the symptom manifests so as to improve the user's skin trouble symptoms. Typically, the "care method" includes information on the care item used for care. The care item information includes information such as the type of care item (product name, etc.), how to use the care item, and precautions for using the care item. The method of using the care item includes information such as the amount to be used, the timing of use (e.g., morning, before going to bed, etc.), and the frequency of use (e.g., once a day, twice a day, once a week, etc.). In addition, the care item includes medicines, non-medicinal quasi-drugs, miscellaneous goods, etc. In this embodiment, all of the care methods proposed to the user include care items, but care methods that do not use special care items such as "ice packs" and "steamed towels" may also be proposed.

[0020] [Service S1] The pharmacist introduction service 96 and schedule adjustment service 97 included in the service S1 introduce a pharmacist suitable for the user who can provide face-to-face consultation on the user's desired date. Based on the user information 90 and the pharmacist information 80, a person who can deal with the user's skin trouble symptoms on the user's desired date included in the user information 90 is extracted as the pharmacist to be introduced. Therefore, the user can finally decide on his / her own care method while consulting face-to-face with a pharmacist suitable for him / her on a date convenient for him / her, and start a skin care program. By consulting face-to-face with a pharmacist who has expertise in medicines, etc., the user can easily dispel anxiety and questions, and can also have the pharmacist directly examine the site where the skin trouble symptoms appear, if necessary, and can start a skin care program with peace of mind. Furthermore, in the information processing system 100, a pharmacist who is more skilled at dealing with skin trouble symptoms can be introduced to the user. As a result, the user can obtain a care method more suitable for the user and information related thereto. In addition, in the information processing system 100, a pharmacist who is more skilled at the life challenges raised by the user can be introduced to the user. This makes it easier for users to improve their quality of life by alleviating issues in their daily lives that accompany skin problems.

[0021] The care method suggestion service 98 suggests a care method suitable for the user to the user. The care method is determined by the server 10 based on the user information 90.

[0022] The monitoring service 99 presents to the user how the user's skin has changed as a result of the execution of the care method proposed in the skin care program in a recognizable manner. For example, the processing unit 14 acquires skin images including the site of the user's skin trouble symptoms immediately before the execution of the care method (immediately before the start of the skin care program) and during the execution of the care method (during the execution of the skin care program), generates a comparison image (monitoring image) in which these skin images are arranged in chronological order for comparison, and presents it to the user. By providing such a monitoring service, the user can confirm the change in the condition of his / her own skin due to the execution of the care method, and is more likely to maintain a good motivation to continue the execution of the care method.

[0023] Here, as a user, for example, there are people who have skin troubles that have recurred despite having previously visited a medical institution for skin troubles or having purchased over-the-counter drugs (OTC (Over The Counter Drug) drugs) at a drug store to deal with the problem. Such people tend to have concerns such as difficulty in determining whether they should visit a medical institution again, and not knowing which over-the-counter drug to choose as a suitable over-the-counter drug for their own skin troubles other than the over-the-counter drug they purchased. The service S1 of this embodiment can introduce such users to a pharmacist who is suitable for the user and can provide face-to-face consultation, thereby resolving the user's concerns.

[0024] [Service S2] In the user information providing service 85 and schedule adjustment service 97 included in the service S2, a user who has a skin trouble symptom that can be treated on a schedule that the pharmacist can handle is introduced to the pharmacist, and the skin information of the user is provided to the pharmacist. The skin information of the user is provided to the pharmacist in advance before the consultation schedule between the pharmacist and the user. Therefore, the pharmacist can give advice to the user after grasping the condition of the site where the skin trouble symptom of the user occurs, and can provide the user with quick and accurate advice in a face-to-face consultation, making it possible to perform an efficient face-to-face consultation. In this embodiment, the skin information includes a skin image of the site where the skin trouble symptom occurs, so that the pharmacist can grasp the condition of the skin trouble symptom in more detail. In addition, in this embodiment, in addition to the skin information, information related to the user's life problems can be provided to the pharmacist, so that the pharmacist can more specifically grasp what kind of trouble the user has with the skin trouble symptom and what kind of information is desired for it.

[0025] The care method suggestion service 87 provides the pharmacist with information on the care method determined by the server 10 based on the user information 90. The pharmacist can refer to the provided information on the care method and determine a care method suitable for the user together with the user during face-to-face consultation while appropriately listening to the user's lifestyle, etc. It is preferable that the care method provided to the pharmacist includes at least the same information as the information on the care method provided to the user, and the pharmacist can share the information on the care method with the user. This makes it easier for the pharmacist to deepen his / her understanding of any questions the user has about the care method. As a result, the pharmacist can give the user more appropriate advice.

[0026] The monitoring information providing service 88 provides the pharmacist with the same information as that provided to the user by the above-mentioned monitoring service 99, such as comparison images. By sharing information in advance between the user and the pharmacist, the user does not need to explain the skin trouble symptoms in detail, and a face-to-face consultation can be made more efficient. In addition, the pharmacist can prepare in advance suggestions such as changing care items or reviewing usage methods while observing changes in the user's skin condition before the face-to-face consultation during monitoring.

[0027] [How to obtain user and pharmacist information] Methods for acquiring user information 90 and pharmacist information 80 include, for example, questionnaires. The questionnaire may be conducted in the form of a questionnaire filled out by the user or pharmacist, or may be conducted directly by a skin care program providing service provider operating server 10 to the user or pharmacist. A questionnaire image may be displayed on display unit 41 of user terminal 1 or display unit 241 of pharmacy terminal 20 via a WEB page or a social networking service (SNS) such as LINE (registered trademark), and a response to the questionnaire image may be input by the user or pharmacist. In this embodiment, an example is given in which a questionnaire image is displayed on the display unit of the terminal and input. A specific example of the questionnaire image displayed on the display unit will be described later.

[0028] (User information) The user information 90 is generated in association with each user based on the results of a questionnaire conducted when signing up for a skin care program, and is stored in the user information DB 153. The user information 90 can be obtained from the questionnaire results. As shown in FIG. 1, the user information 90 includes, for example, user skin information 91, user life task information 92, user consultation request information 93, user attribute information 94, and current treatment information 95, each associated with a user. The user information 90 may also include user request information, such as the user's specific requests regarding life tasks and the gender of the pharmacist to be treated.

[0029] The skin information 91 includes manifestation site information 911 where the user's skin trouble symptom is manifested, and symptom information 912 indicating the skin trouble symptom at the manifestation site. The "symptom manifestation site" is the site to be cared for. Furthermore, the skin information 91 may include manifestation site image information 913. The manifestation site image information 913 may be acquired, for example, by an imaging unit 6 (see FIG. 3 ) described below mounted on the user terminal 1. The skin information 91 may also include symptom degree information 914 indicating the degree of the skin trouble symptom, and manifestation frequency information 915 indicating the occurrence frequency of the skin trouble symptom.

[0030] The above-mentioned life problem information 92 is information on the user's worries and problems in life associated with skin trouble symptoms. The life problem information 92 includes, for example, a life problem about makeup method such as wanting to know how to make makeup that makes skin trouble symptoms less noticeable because you are concerned about skin trouble symptoms, a life problem about skin care method such as wanting to know basic cosmetics suitable for your skin trouble symptoms, a life problem about the cycle at which skin troubles appear and in what seasons they tend to appear, a life problem about nutritional guidance such as wanting to know foods that help improve your skin trouble symptoms and foods that tend to worsen your skin trouble symptoms, and a life problem about bedding and clothing such as wanting to know how to choose bedding and clothing suitable for your skin trouble symptoms.

[0031] The consultation request information 93 includes desired date information 931 and desired area information 932. The desired date information 931 indicates a desired date for a face-to-face consultation with a pharmacist desired by the user. The desired area information 932 indicates a desired area for a face-to-face consultation with a pharmacist desired by the user.

[0032] The user attribute information 94 includes general information such as name, age (generation), occupation, address (area of ​​residence), sex, contact information such as email address, and user ID (user identification information) for identifying the user. The user ID is given to the user by the server 10 when the user applies for membership registration. The user ID may function as account information for using various services in the information processing system 100.

[0033] The current treatment information 95 is information on the care method currently being taken by the user for the skin trouble symptoms. The information includes consultation information indicating whether the user has visited a medical institution to improve the skin trouble symptoms that concern him or her, information on care items currently being used, and the like. By providing the user's current treatment information to the pharmacist in advance, the pharmacist can give advice to the user after understanding the treatment methods the user has taken so far. Therefore, it is possible to provide accurate advice to the user. In addition, it is possible for the pharmacist to know in advance symptoms such as recurrent skin troubles that cannot be dealt with by visiting a medical institution or by care with OTC drugs alone.

[0034] (Pharmacist Information) Pharmacist information 80 of each pharmacist can be obtained from the survey results. The pharmacist information 80 is prepared in advance and stored in the pharmacist information DB 154. The pharmacist information 80 is generated based on the survey results in association with the pharmacist. As shown in FIG. 1, the pharmacist information 80 includes, for example, skin trouble symptom information 81 that the pharmacist can handle, lifestyle task information 82 that the pharmacist can handle, schedule information 83 that the pharmacist can handle, and pharmacist attribute information 84, each of which is associated with a plurality of pharmacists.

[0035] The above-mentioned treatable skin trouble symptom information 81 is information about skin trouble symptoms that the pharmacist can treat, and in this embodiment, the degree of treatability is expressed as a symptom treatability evaluation value (described later). Although a specific example will be described later, in the questionnaire, the pharmacist may answer each skin trouble symptom in a two-level evaluation of difficult to treat or possible to treat, or may answer in a three-level evaluation that further reflects the pharmacist's degree of expertise in dealing with skin trouble symptoms. In this embodiment, an example is given in which the pharmacist answers in a three-level evaluation that reflects the degree of expertise of difficult to treat (not good at), possible to treat with normal degree of expertise, and possible to treat with high degree of expertise. For example, if the pharmacist himself or a parent, sibling, spouse, child, etc. close to the pharmacist currently or in the past has or has had a skin trouble symptom, the pharmacist, as a person who has experienced skin trouble or as a person who has experience in skin trouble care, will have a deeper understanding of skin trouble symptoms and will be more likely to understand the feelings of people with skin trouble symptoms than those who have no experience. In such a case, the pharmacist can answer in the questionnaire that he or she is highly skilled in the skin trouble symptom. Even if a pharmacist has never experienced a skin trouble himself or herself, and has no one close to him or her who has a skin trouble, he or she can answer that the pharmacist is highly skilled in the skin trouble based on his or her own experience, for example, by having seen many people with a certain skin trouble. In this way, the pharmacist information 80 is generated with the degree of expertise for each skin trouble reflected, so that a pharmacist who is more skilled in the skin trouble that the user has can be introduced more easily, and a pharmacist suitable for the user can be introduced. In addition, since there is generally no skin trouble that a pharmacist cannot handle, in the questionnaire regarding the skin trouble that can be handled, typically, the answer is either "possible" and "normal" or "possible" and "high"

[0036] The above-mentioned life task information 82 that can be handled is information about life tasks that the pharmacist can handle, and in this embodiment, the degree of handling is expressed as a life task handling evaluation value (described later). Examples of life tasks include makeup methods, skin care, nutritional guidance, and bedding and clothing. In the questionnaire, the pharmacist may answer each life task in a two-level evaluation of difficult to handle or possible to handle, or may answer in a three-level evaluation that further reflects the pharmacist's level of expertise in the life task. In this embodiment, an example is given in which the pharmacist answers in three levels that reflect the level of expertise: difficult to handle (not good at), possible to handle and normal level of expertise, and possible to handle and high level of expertise. For example, if the pharmacist himself or a parent, sibling, spouse, child, etc. close to the pharmacist currently or in the past has or has had skin trouble symptoms, the pharmacist, as a person who has experienced skin trouble or has experience in skin trouble care assistance, is likely to have a deeper understanding of the life tasks associated with skin trouble compared to those who have no experience. In such a case, the pharmacist can answer in the questionnaire that he or she is highly skilled in the life task. Even if a pharmacist has never experienced a skin trouble, and has never known anyone with a skin trouble, the pharmacist may answer that he / she is highly skilled in the lifestyle problems associated with the skin trouble based on his / her own experience, for example, by having seen many people with a certain skin trouble. In addition, if the pharmacist is able to give detailed advice on the lifestyle problems, for example, by being good at hiding the skin trouble with makeup, being well aware of skin-friendly skin care methods, being well aware of foods that are good for the skin, being well aware of bedding and clothing materials that are gentle on the skin, etc., the pharmacist may answer in the questionnaire that he / she is highly skilled in the lifestyle problems associated with the skin trouble. In this way, the pharmacist information 80 is generated reflecting the degree of skill in the lifestyle problems associated with the skin trouble, so that a pharmacist who is more skilled in the lifestyle problems associated with the skin trouble that the user has can be introduced, and a pharmacist suitable for the user can be introduced.

[0037] The available schedule information 83 is information about the schedule when the pharmacist can consult with the user face-to-face about the care method. The available schedule information may be, for example, information about the days of the week and the time period when the pharmacist works at the pharmacy, or, in the case of an irregular work schedule, the available schedule may be input by the user at any time.

[0038] The pharmacist attribute information 84 includes general information such as the pharmacist's name, pharmacist ID (pharmacist identification information), sex, age (generation), and affiliated pharmacy information to which the pharmacist belongs. The pharmacist ID is for identifying the pharmacist, and is assigned to the pharmacist by the server 10 upon application for pharmacist registration. The affiliated pharmacy information includes information such as the pharmacy name, pharmacy ID (pharmacy identification information), pharmacy address, pharmacy contact information such as the pharmacy's telephone number and email address, and the pharmacy's business days and business hours. The pharmacy ID is assigned to the pharmacy terminal 20 by the server 10 upon application for pharmacist registration. If a pharmacy ID has already been assigned to the pharmacy terminal 20 upon application for pharmacist registration, this pharmacy ID is used. The pharmacist ID may function as account information for the pharmacist to use various services in the information processing system 100.

[0039] <Server hardware configuration> As shown in FIG. 2, the server 10 includes a central processing unit (CPU) 31, a read only memory (ROM) 32, a random access memory (RAM) 33, an input / output interface 35, and a bus 34 connecting these to each other.

[0040] The CPU 31 appropriately accesses the RAM 33 etc. as necessary, and performs various arithmetic processing while controlling all the blocks of the server 10. The ROM 32 is a non-volatile memory in which the OS, programs, various parameters, and other firmware to be executed by the CPU 31 are fixedly stored. The RAM 33 is used as a working area for the CPU 31, and temporarily stores the OS, various applications being executed, and various data being processed.

[0041] The input / output interface 35 is connected to a display unit 36, an operation reception unit 37, a storage unit 38, a communication unit 39, and the like.

[0042] The display unit 36 ​​is a display device using, for example, an LCD (Liquid Crystal Display) or an OELD (Organic Electro Luminescence Display).

[0043] The operation reception unit 37 is, for example, a pointing device such as a mouse, a keyboard, a touch panel, or other input device. When the operation reception unit 37 is a touch panel, the touch panel can be integrated with the display unit .

[0044] The storage unit 38 is, for example, a non-volatile memory such as a hard disk drive (HDD), a flash memory (SSD; Solid State Drive), or other solid-state memory. The storage unit 38 stores the OS, various applications, and various data.

[0045] The communication unit 39 is, for example, a NIC (Network Interface Card) for Ethernet or various modules for wireless communication such as wireless LAN, and is responsible for communication processing between the user terminal 1 and the pharmacy terminal 20.

[0046] Although not shown, the basic hardware configurations of the user terminal 1 and the pharmacy terminal 20 are substantially the same as the hardware configuration of the server 10. It is preferable that the user terminal 1 has a camera for photographing skin connected to the bus 34 directly or via the input / output interface 35; specifically, a so-called smartphone satisfies this requirement.

[0047] <Functional configuration of information processing system> As shown in Fig. 3, information processing system 100 includes user terminal 1, server 10 as an information processing device, and pharmacy terminal 20. User terminal 1, pharmacy terminal 20, and server 10 can be connected via a wireless or wired communication network, and data can be transmitted and received via the communication network. The communication network is, for example, the Internet 50 (see Fig. 1).

[0048] [User terminal functional configuration] 1 and 3, the user terminal 1 is a terminal carried by a user who has a skin trouble symptom and uses a skin care program. The user terminal 1 is, for example, a mobile phone such as a smartphone, a tablet terminal, a personal computer, etc. As shown in FIG. 3, the user terminal 1 has a communication unit 2, an input unit 3, an output unit 4, a processing unit 5, an imaging unit 6, and a storage unit 7.

[0049] The communication unit 2 transmits and receives various information to and from the server 10 via the Internet 50, for example.

[0050] The input unit 3 is, for example, an input device such as a touch panel, a touch pad, a pen tablet, a pointing device such as a mouse, or a keyboard. The input unit 3 may also include a microphone and may be capable of voice input. When the input unit 3 includes a touch panel, the touch panel may be integrated with a display unit 41 described later.

[0051] The output unit 4 is an output device that presents various information. In this embodiment, the output unit 4 includes a display unit 41. The display unit 41 is configured with an image display panel such as a liquid crystal display or an organic EL display. The display unit 41 is capable of displaying based on the presentation information received by the communication unit 2 from the server 10. For example, the display unit 41 displays a questionnaire image (input image) for inputting user information, a pharmacist information provision image for providing pharmacist information to the user, a care method image showing a care method, etc., a monitoring image, etc.

[0052] The processing unit 5 controls, for example, image display on the display unit 41. Specifically, the processing unit 5 causes the display unit 41 to display an image based on the presentation information received by the communication unit 2. The processing unit 5 also controls the input information input by the user to the questionnaire image to be transmitted to the server 10 via the communication unit 2.

[0053] The imaging unit 6 can capture, for example, an image of the skin including the symptom manifestation site of the user using the user terminal 1. For example, a camera equipped with an image sensor such as a CMOS (Complementary Metal Oxide Semiconductor) or a CCD (Charge Coupled Devices) sensor is used as the imaging unit 6. The imaging unit 6 can capture images of the skin of the symptom manifestation site before purchasing a skin care program, immediately before starting the program, during the implementation period, and at the end of the implementation period.

[0054] The storage unit 7 may store, for example, various information transmitted and received by the communication unit 2 to and from the server 10. For example, a captured skin image may be stored in the storage unit 7. This makes it possible to eliminate the need to transmit the skin image from the server 10 to the user terminal 1, thereby reducing the amount of communication data. Furthermore, by storing information on the user terminal 1 side, the processing speed and operability on the user terminal 1 side can be improved, and even in a poor communication environment, for example, processing is less likely to be delayed, thereby reducing the psychological burden on the user due to slow processing speed.

[0055] [Pharmacy terminal functional configuration] 1 and 3, pharmacy terminal 20 is installed in a pharmacy to which a pharmacist belongs. Pharmacy terminal 20 is, for example, a mobile phone such as a smartphone, a tablet terminal, a personal computer, etc. As shown in FIG. 3, pharmacy terminal 20 has communication unit 22, input unit 23, output unit 24, processing unit 25, and storage unit 27.

[0056] The communication unit 22 transmits and receives various information to and from the server 10 via the Internet 50, for example.

[0057] The input unit 23 is, for example, an input device such as a touch panel, a touch pad, a pen tablet, a pointing device such as a mouse, or a keyboard. The input unit 23 may also include a microphone and may be capable of voice input. When the input unit 23 includes a touch panel, the touch panel may be integrated with a display unit 241 described later.

[0058] The output unit 24 is an output device that presents various information. In this embodiment, the output unit 24 includes a display unit 241. The display unit 241 is configured with an image display panel such as a liquid crystal display or an organic EL display. The display unit 241 is capable of displaying information based on the presentation information received by the communication unit 2 from the server 10. For example, the display unit 241 displays a questionnaire image for inputting pharmacist information, a user information providing image showing the user's skin information, a care method image showing a care method, etc.

[0059] The processing unit 25 controls, for example, image display on the display unit 241. Specifically, the processing unit 25 causes the display unit 241 to display an image based on the presentation information received by the communication unit 22. The processing unit 25 also controls the input information input by the user in the questionnaire image to be transmitted to the server 10 via the communication unit 22.

[0060] The storage unit 27 may store various information that the communication unit 22 transmits and receives to and from the server 10, for example.

[0061] [Server (information processing device) functional configuration] The server 10 serving as an information processing device includes a communication unit 11, a processing unit 14, and a storage unit 15.

[0062] The communication unit 11 transmits and receives various information to and from the user terminal 1 and the pharmacy terminal 20 via, for example, the Internet.

[0063] The processing unit 14 performs a series of processes related to the provision of the above-mentioned services S1 and S2. The processing unit 14 executes a pharmacist extraction process, a care method determination process, a monitoring process, a presentation information generation process, and the like.

[0064] The processing unit 14 performs pharmacist extraction processing related to the pharmacist introduction service 96, the schedule adjustment service 97, and the schedule adjustment service 86. The processing unit 14 extracts a pharmacist suitable for the user who is available for consultation on the schedule desired by the user, based on the user information 90 and the pharmacist information 80 (pharmacist extraction processing).

[0065] The processing unit 14 performs a care method determination process related to the care method suggestion service 98 and the care method suggestion service 87. The processing unit 14 determines a care method suitable for the user based on the user information 90 by referring to a table stored in the care method DB 152 (care method determination process).

[0066] The processing unit 14 performs monitoring services 99 and monitoring It performs monitoring processing related to the information providing service 88. The processing unit 14 monitors changes over time in the skin caused by the execution of the care method (monitoring processing).

[0067] In the monitoring process, for example, skin images of the user's symptom site are periodically acquired, and a plurality of skin images acquired at different times are compared to check how the skin has changed due to the execution of the care method (skin care program). For example, the processing unit 14 generates, as the presentation information, an image in which the skin images are arranged in chronological order as a result of the monitoring process.

[0068] The processing unit 14 may obtain an index value of the skin condition as a result of the monitoring process in addition to or instead of the images of the skin at the symptom manifestation site arranged in time series, and may display the change in the index value. The change in the index value over time may be displayed as a graph or may be expressed as a numerical value. The index value is a quantitative evaluation of the skin condition at the symptom manifestation site. Examples of the index value include skin barrier function, skin unevenness (redness), skin itching, etc. A higher numerical value of the index value indicates a higher skin barrier function in the barrier function, a reduced skin unevenness (redness) in the unevenness (redness), and a reduced skin itching in the itching. One or more index values ​​selected from the skin barrier function, skin unevenness (redness), and skin itching may be determined as the index value.

[0069] As an example, the processing unit 14 may determine an analysis value obtained by performing image analysis on the acquired skin image of the user using a known image analysis method as an index value of the skin barrier function. In the image analysis related to the skin barrier function, it is possible to grasp structural changes in the skin surface, such as the strength of the skin against external stimuli, the state of the recurrence of symptoms, the smoothness of the skin surface, and the state of scales (whether they have decreased, etc.). In addition, the processing unit 14 may determine an analysis value obtained by performing image analysis on the acquired skin image of the user using a known image analysis method as an index value of skin unevenness (redness). In the image analysis related to skin unevenness (redness), it is possible to grasp color changes, such as changes in the redness of the skin and a decrease in redness unevenness. In this way, by obtaining an index value through image analysis, it is possible to objectively evaluate the skin condition, such as the skin barrier function and skin unevenness (redness). In addition to the analysis result of the skin image, which is an objective evaluation, the barrier function and unevenness (redness) index values ​​may be determined by taking into account the subjective evaluation by the user.

[0070] Here, when an image is acquired under different photographing conditions, the color tone of the skin image, such as brightness, contrast, and density, may differ. From the viewpoint of obtaining an index value suitable for comparison, it is preferable to photograph the skin image with a correction sticker attached to the user's skin, for example. The correction sticker has a color correction area colored with a known hue, saturation, and brightness. By adjusting the color tone of the skin image based on this color correction area and obtaining an index value, the accuracy of the comparative evaluation of the skin using the index value is improved.

[0071] In this embodiment, an example is given in which skin images of symptom manifestation sites are arranged in chronological order as the monitoring process result. In this case, the user may take a picture of the skin with a correction sticker attached, adjust and process the color of the skin image based on the color correction area of ​​the correction sticker, and arrange the processed skin images in chronological order. This allows the user to grasp the change in skin over time more accurately.

[0072] The processing unit 14 may also determine the index value of itching using the results of a questionnaire about itching input by the user. In other words, the index value of a skin condition such as itching, which is difficult to judge by image analysis, is determined based on the subjective evaluation by the user. For example, the index value can be set to 4 when there is no itching, 3 when there is mild itching, 2 when there is moderate itching, and 1 when there is severe itching.

[0073] The processing unit 14 generates presentation information to be presented on the display unit 41 of the user terminal 1 (presentation information generation process). The presentation information is typically image information (image signal), and will be described below as image information.

[0074] Specifically, the processing unit 14 generates, as presentation information (image information) to be presented to the user terminal 1, a questionnaire image (input image) for acquiring user information, a pharmacist information provision image for providing the user with information on a pharmacist to consult with in relation to the pharmacist introduction service 96, a care method image for proposing a care method in relation to the care method proposal service 98, a monitoring image showing a monitoring result in relation to the monitoring service 99, and the like. The processing unit 14 transmits the generated image information to the user terminal 1 via the communication unit 11. In the user terminal 1, an image is displayed on the display unit 41 based on the image information.

[0075] Furthermore, processing unit 14 generates presentation information (image information) to be displayed on display unit 241 of pharmacy terminal 20 (presentation information generation process).

[0076] Specifically, processing unit 14 generates, as presentation information (image information) to be presented on pharmacy terminal 20, a questionnaire image (input image) for acquiring pharmacist information, a user information providing image for providing user information of a user to be consulted in user information providing service 85, a care method image for providing information of a care method proposed to a user in care method suggestion service 87, and a monitoring information providing image showing a monitoring result of the user's skin in monitoring information providing service 88. Processing unit 14 transmits the generated presentation information to pharmacy terminal 20 via communication unit 11. In pharmacy terminal 20, an image is displayed on display unit 241 based on the presentation information.

[0077] (Storage part) The storage unit 15 includes a program storage unit 151, a care method DB 152, a user information DB 153, and a pharmacist information DB 154. The storage unit 15 corresponds to the storage unit 38 in the hardware configuration of FIG.

[0078] ((Program Memory Section)) The program storage unit 151 stores programs for executing a pharmacist extraction process, a care method determination process, a monitoring process, a presentation information generation process, and the like, which are performed in the information processing system 100. The programs may be read from a portable recording medium such as an optical disk or a semiconductor memory, or may be downloaded from a server on a network.

[0079] The program storage unit 151 stores a program for causing the server (information processing device) 10 of the information processing system 100 to execute the pharmacist extraction process. The program includes the steps of: acquiring skin information including symptom information indicating a skin trouble symptom of a user, and desired schedule information indicating a desired schedule of the user for the user to consult with a qualified pharmaceutical distributor about the skin trouble symptom, acquiring previously prepared available schedule information of each of a plurality of qualified pharmaceutical distributors and available skin trouble symptom information regarding the skin trouble symptoms that each of the plurality of qualified pharmaceutical distributors can handle, and extracting a qualified pharmaceutical distributor who can handle the skin trouble symptom of the user included in the symptom information on the desired schedule included in the desired schedule information as a qualified pharmaceutical distributor to be introduced to the user from among the plurality of qualified pharmaceutical distributors based on the available schedule information and the available skin trouble symptom information.

[0080] ((Care Method DB)) The care method DB 152 stores a table including care method information in which a plurality of care methods for caring for the skin trouble symptom manifestation area are associated with each skin trouble symptom, as shown in Fig. 4 and Fig. 5. The table has data in which care methods, skin trouble symptoms, and symptom manifestation areas (simply written as "areas" in the figures) are associated with each other. For convenience, Fig. 4 and Fig. 5 use eczema, rash, redness, itchiness, roughness, and darkening as examples of symptoms.

[0081] The "care method" item in the table includes information on care items that can care for skin trouble symptoms. The care method information includes care item information in which a plurality of care items are associated with each skin trouble symptom. The care items may include essential care items for carrying out the care method and optional care items that the user can select whether or not to use. The essential care items are essential care items proposed to solve the skin trouble symptoms that the user is currently suffering from. The optional care items are care items proposed to further enhance the care method using the essential care items. In this embodiment, all of the care methods stored in the care method DB 152 are configured to include care items, but there may also be care methods that do not use special care items such as "ice packs" and "steamed towels."

[0082] The care method DB 152 may store information on the timing and method of use for each care item. For example, when multiple care items with the same efficacy are proposed for a certain symptom, the pharmacist can accurately explain the differences between the items and provide advice on selecting an item that suits the user's lifestyle based on the information on the timing and method of use for each care item. The information on the timing and method of use may be sent to both the user and the pharmacist, or may be sent only to the pharmacist.

[0083] The "skin trouble symptom" item in the table indicates the symptom of the target part for which the corresponding "care method" is to be performed. The "part" item in the table indicates the part where the symptom appears, i.e., the body part for which the "care method" is to be performed.

[0084] ((User Information DB)) The user information DB 153 stores user information 90 (see FIG. 1) for each user who receives the service S1.

[0085] As described above, the user information 90 includes skin information 91, life task information 92, consultation request information 93, user attribute information 94, current treatment information 95, etc. These pieces of information are mainly acquired by a questionnaire before purchase. As expression site image information 913 included in the skin information 91, the skin image is associated with the acquisition date and time of the skin image, an index value, etc., and stored. As the skin image, a skin image immediately before the start of a skin care program, a skin image periodically acquired after the start of the skin care program, etc. may be stored, so that changes in the skin over time due to the execution of the skin care program can be grasped.

[0086] In addition, the user information DB 153 stores, for each user, pharmacist information 80 (e.g., a pharmacist ID) of the pharmacist who is extracted based on the user information 90 and the pharmacist information 80 and determined to be the user's consultation partner, linked to consultation schedule information with the pharmacist.

[0087] In addition, the user information DB 153 may store, for each user, information on the care method proposed by the processing unit 14 linked to information on the care method that the user ultimately purchased after face-to-face consultation with a pharmacist (purchase history information).

[0088] Furthermore, evaluation results such as impressions and findings on a skin care method related to a skin care program that the user is performing or has performed may be stored for each user in the user information DB 153. The evaluation results on the skin care method can be obtained by a questionnaire, for example, when a skin image is obtained for the second or subsequent time.

[0089] (Pharmacist Information DB) The pharmacist information DB 154 stores, for each pharmacist, pharmacist information 80 (see FIG. 1) of the pharmacist who is to receive the service S2. As shown in FIGS. 1 and 7, the pharmacist information 80 includes treatable skin trouble symptom information 81, treatable life task information 82, treatable schedule information 83, and pharmacist attribute information 84. These pieces of information are acquired in advance by a questionnaire. In addition, the pharmacist information DB 154 stores, for each pharmacist, user information 90 of a user who will be consulted and consultation schedule information with the user, linked to each other.

[0090] <Information processing method> The information processing method performed by the processing unit 14 of the server 10 in the information processing system 100 will be described separately for before the skin care program starts and after the skin care program starts. Before the skin care program starts, pharmacist information is acquired in advance to provide services S1 and S2. Below, in the explanation before the skin care program starts, the information processing method related to the acquisition of pharmacist information will be explained, and then the information processing method related to the provision of services S1 and S2 will be explained. In the following explanation, a specific image displayed on the display unit 41 of the user terminal 1 or the display unit 241 of the pharmacy terminal 20 will be used as an example, but this is just one example and is not limited to the image content.

[0091] [Before starting the skin care program] (Information processing method for obtaining pharmacist information) Following the flow of FIG. 8, an information processing method for acquiring pharmacist information will be described with reference to FIG. 6 and FIG.

[0092] The following description will be given following the flow of Fig. 8. When processing unit 14 of server 10 receives a registration request from pharmacy terminal 20 that has accessed the site it operates (ST1), it transmits a questionnaire image (presentation information) for acquiring pharmacist information to pharmacy terminal 20 (ST2). Based on the received presentation information, pharmacy terminal 20 displays questionnaire images (input images) 28A-28C shown in Figs. 6(A)-(C) on display unit 241. When the pharmacist inputs answers to the questions in questionnaire images 28A-28C and taps or clicks send button 29, the questionnaire results (pharmacist information) are transmitted to server 10.

[0093] 6A shows questionnaire image 28A, which displays fields for obtaining attribute information of the pharmacist. For example, questionnaire image 28A shows questions such as the pharmacist's name, the schedule when the pharmacist can consult with the user (e.g., the days of the week and the hours when the pharmacist can consult with the user), the gender, the name of the pharmacy, the address of the pharmacy, the contact information of the pharmacy (e.g., a telephone number, an email address, etc.), the business days and business hours of the pharmacy, etc.

[0094] The questionnaire image 28B shown in FIG. 6B displays question 1 (Q.01) for obtaining information on skin trouble symptoms that the pharmacist can handle. Examples of skin trouble symptoms include "eczema (bumps) / rash," "redness," "itchiness," "cracking / chapping," "blackheads," "roughness / stiffness / flaking / peeling," "acne / pimples," and "scars." In this embodiment, the questions are answered using a three-level evaluation (called "symptom handling ability evaluation") that reflects the pharmacist's level of expertise in dealing with skin trouble symptoms. Specifically, the pharmacist is instructed to answer with 1 if it is difficult to handle (not good at it), 2 if it is possible to handle it and the level of expertise is normal, and 3 if it is possible to handle it and the level of expertise is high. These numerical values ​​from 1 to 3 are called "symptom handling ability evaluation values."

[0095] The questionnaire image 28C shown in FIG. 6(C) displays question 2 (Q.02) for obtaining information on life tasks that the pharmacist can handle. Examples of life task information include "makeup method," "skin care," "nutritional guidance," and "bedding and clothing." Question 2 asks whether advice on these life tasks can be provided to the user. In this embodiment, the question is answered with a three-level evaluation (called "life task handling ability evaluation") that reflects the pharmacist's level of expertise in life tasks. Specifically, the user is instructed to answer with 1 if it is difficult to handle (not good at it), 2 if it is possible to handle it and the level of expertise is normal, and 3 if it is possible to handle it and the level of expertise is high. These numerical values ​​from 1 to 3 are called "life task handling ability evaluation values."

[0096] The processing unit 14 acquires the survey result information by the pharmacist (information entered in the survey image in Figures 6(A) to (C)) (ST3). When the processing unit 14 acquires the survey result information, it issues a pharmacist ID. Furthermore, if the pharmacy to which the pharmacist belongs has not yet been registered and a pharmacy ID has not been assigned, a pharmacy ID is issued. If the pharmacy has already been registered, an existing pharmacy ID is used. Based on the acquired survey result information by the pharmacist, the processing unit 14 generates pharmacist information 80, for example, as shown in Figure 7 (ST4), and stores the information in the pharmacist information DB 154 (ST5).

[0097] In this embodiment, when a registration request is made by a pharmacist, a pharmacist ID is issued, and pharmacist information 80 is stored in pharmacist information DB 154, the pharmacist becomes able to receive service S2.

[0098] (Information processing method related to service provision) The information processing related to the service provision by the information processing system 100 will be described with reference to FIGS. 9 to 12 and 14, following the flows of FIGS. 13, 15 to 17. FIG.

[0099] The following description will be given according to the flow of Fig. 13. When the processing unit 14 of the server 10 receives a skin care program usage request from the user terminal 1 that has accessed the site operated by the server 10 (ST10), the processing unit 14 transmits a questionnaire image (presentation information) for acquiring user information to the user terminal 1 (ST11). Based on the received presentation information, the user terminal 1 displays, on the display unit 41, questionnaire images (input images) 70 (70A-70C) shown in Figs. 9(A)-(C) and questionnaire images 70 (70D, 70E) shown in Figs. 10(A) and (B). When the user inputs answers to the questions shown in the questionnaire images 70A-70E and taps or clicks the send button 29, the questionnaire results (user information) are transmitted to the server 10.

[0100] Question 1 (Q.01) and question 2 (Q.02) for obtaining skin information of the user are displayed in a questionnaire image 70A shown in FIG. 9(A).

[0101] Question 1 asks about the details of skin trouble symptoms as the user's skin information. In the example shown in FIG. 9(A), multiple symptoms are displayed in advance and can be selected by the user. In the example shown in FIG. 9(A), options are displayed as skin trouble symptoms, including "eczema (bumps) / rash," "redness," "itchiness," "cracking / chapping," "darkening," "roughness / stiffness / flaking / peeling," "acne / pimples," "scars," and "other." Here, an example is given in which the user selects one symptom, but the configuration may be such that more than one symptom can be selected.

[0102] Question 2 (Q.02) asks the user about the part where the skin trouble symptom is manifested (symptom manifestation part) and the degree of the symptom as the user's skin information. In the example shown in FIG. 9(A), a full body view of the human body viewed from the front and the back is displayed. The user can input the symptom manifestation part by specifying the part where the skin trouble symptom is manifested using the full body view, and can intuitively and accurately indicate the symptom manifestation part. In addition, in the example shown in FIG. 9(A), the degree of the symptom can be input by the number of times of tapping or clicking the symptom manifestation part. One tap or click indicates that the symptom is mild. Two taps or clicks indicate that the symptom is moderate. Three taps or clicks indicate that the symptom is severe. In this way, the degree of the symptom can be input by the number of taps or clicks, and input operability is good. In addition, the color of the specified symptom manifestation part on the image may change depending on the degree of the symptom, and the user can intuitively confirm the degree of the input symptom by the change in color. In addition, the input of the specification of the symptom manifestation part and the input of the degree of the symptom may be canceled by four taps or clicks. Then, by canceling the input once, the next new tap or click may be counted as 1. This allows a new input to be made after canceling the previous input, even if the input of the designated area of ​​skin trouble symptoms or the input of the severity of symptoms is incorrect.

[0103] In the example shown in FIG. 9(B), a questionnaire image 70B displays question 3 (Q.03) for obtaining skin information of the user and question 4 (Q.04) for obtaining life task information.

[0104] Question 3 asks about the frequency of occurrence of skin trouble symptoms (occurrence frequency) as skin information of the user. In the example shown in Fig. 9(B), the frequency of occurrence is displayed with six options: "always," "more than once a week," "about once every 2-3 weeks," "about once a month," "about once every 2-3 months," and "less frequently than once every 2-3 months."

[0105] Question 4 asks about life issues such as worries and problems. Specifically, it asks about worries and problems in life associated with skin trouble symptoms. While questions 1 to 3 above are questions to obtain skin information from the user, question 4 asks about the impact of skin trouble symptoms on the quality of life.

[0106] In the example shown in FIG. 9(C), question 5 (Q.05) for obtaining information on the countermeasure (care method) currently being taken by the user is displayed in questionnaire image 70C.

[0107] Specifically, question 5 asks how the user is currently dealing with skin trouble symptoms. In the example shown in Fig. 9(C), the user is instructed to select all that apply from eight options.

[0108] Also, although not shown in Figure 9(C), if "I am using medicines prescribed by a doctor" or "I am using medicines purchased at a pharmacy or drugstore" is checked in question 5, the name of the medicine (care item name) being used may be made available for input.

[0109] In the example shown in FIG. 10(A), question 6 (Q.06) asking about the desired area for consultation with a pharmacist and question 7 (Q.07) asking about the desired date for consultation with a pharmacist are displayed in questionnaire image 70D.

[0110] The desired area is an area where the user wishes to have a face-to-face consultation with a pharmacist. In the example image shown in FIG. 10(A), a number of area names are displayed as areas, and the user can select one or more. The area may be a train or bus stop name, in addition to the area name. The user can select an area that is convenient for use according to his / her lifestyle, such as near his / her home, near his / her workplace, or near a station he / she regularly uses. The user can also select an area that is unfamiliar to him / her, and for example, a face-to-face consultation is possible at a pharmacy located at a long-term business trip destination or travel destination.

[0111] In this embodiment, a face-to-face consultation with a pharmacist is possible even during the execution of a skin care program. The user can set different areas for the first face-to-face consultation with a pharmacist and the second and subsequent face-to-face consultations with a pharmacist that can be performed according to the user's wishes. Here, the user information DB 153 stores user information 90 including the user's skin image, information on the care items used by the user in the skin care program (care items that are finally determined in the first face-to-face consultation with a pharmacist, and are typically included in the purchase history information), and the like. For this reason, even if the user is not the first face-to-face consultation partner, the pharmacist can obtain the user information stored in the user information DB 153 in advance and can give appropriate advice to the user. Furthermore, since the user information includes a skin image of the skin trouble onset site, the pharmacist can more accurately grasp the skin condition and the changes in the skin condition to date. In addition, even if the pharmacist to be consulted has changed since the last time, the user does not need to explain in detail his / her own skin condition or the care method currently being performed, and therefore can have an efficient consultation. Furthermore, the user does not need to adjust the execution period of the skin care program to fit their schedule, such as a long-term business trip or travel, and can execute the skin care program at any time when they are concerned about their skin trouble symptoms.

[0112] The desired date is a date when the user wishes to have a face-to-face consultation with a pharmacist. In the example image shown in Fig. 10(A), the user is prompted to enter the first to third options of the desired consultation date and the desired time slot.

[0113] In the example shown in FIG. 10(B), the questionnaire image 70E displays question 8 (Q.08) and question 9 (Q.09) which ask about requests regarding face-to-face consultation with a pharmacist. In question 8, for example, the gender of the desired pharmacist is asked. For example, if the user wants to specify the gender of the pharmacist, for example, if the user feels uncomfortable about having a pharmacist of the opposite sex see his / her skin with skin trouble symptoms, or if it is easier to consult with a pharmacist of the same sex, the user can specify the gender of the pharmacist. This makes it possible to provide the user with an environment in which it is easy to have a face-to-face consultation with a pharmacist. In question 9, the user can freely write in his / her requests. The user can write in more specific problems, etc. This allows the pharmacist to provide more appropriate advice, etc. according to the user's requests.

[0114] In addition, the display unit 41 of the user terminal 1 displays a questionnaire image asking about general attribute information of the user, such as name, age (generation), occupation, address (residential area), sex, and contact information such as email address.

[0115] In the user terminal 1, the user inputs answers to the questions in each of the questionnaire images 70 (70A to 70E) displayed on the display unit 41, which ask about user attribute information, and then taps or clicks the send button, thereby transmitting the survey result information to the server 10.

[0116] Next, the processing unit 14 acquires user information (input information) which is the questionnaire result from the user terminal 1 (ST12). Next, the processing unit 14 acquires care method information from the care method DB 152 (ST13), refers to the care method information, and determines a care method based on the user information 90 (ST14). The care method is provided to the user, and also to a pharmacist who is a consultation partner of the user.

[0117] An example of the care method determined in ST14 will be described. For example, when "itchiness" is listed in the symptom information (skin trouble symptom information) 912 of the user information 90 and "neck" is listed in the manifestation site information (skin trouble symptom manifestation site information) 911, the processing unit 14 determines from the care method information shown in Figs. 4 and 5 whether "neck" is listed as an anti-inflammatory topical agent A topical preparation (care method No. 1), an anti-inflammatory topical agent E mist preparation (care method No. 5), a medicated cleanser (care method No. 12), a UV protection agent A topical preparation (care method No. 13), or a combination of these. The following were extracted and determined as the care methods to be presented to users and pharmacists: UV protection agent B mist formulation (care method No. 20), sweat wipes C (care method No. 23), allergen adhesion prevention agent A applied formulation (care method No. 24), allergen adhesion prevention agent B mist formulation (care method No. 25), bath additives B (care method No. 34), beverage C (care method No. 38), and scratch protection means (care method No. 39).

[0118] In this way, multiple formulations with the same efficacy but different application means, such as a spread type or a spray type (mist type), may be extracted. Since the user can purchase a care item while receiving advice from a pharmacist in a face-to-face consultation with a pharmacist, the user can finally select and decide on a care item that suits him / her with confidence by listening to the pharmacist's advice on which of the formulations with different application means with the same efficacy is suitable for him / herself, the efficacy of the formulation and characteristics other than the efficacy of the formulation (for example, a spread type is white when applied and the color of the formulation tends to remain, but a spray type has a color that is not noticeable, etc.).

[0119] Next, the processing unit 14 generates a care method image 71 (71A to 71C shown in Fig. 11 and Fig. 12) displaying the care method determined in ST14 as presentation information, and transmits it to the user terminal 1 (care method suggestion service 98). The user terminal 1 displays the care method image 71 (71A to 71C) on the display unit 41 based on the presentation information transmitted from the server 10, as shown in Figs. 11 and 12.

[0120] As shown in FIG. 11, the display unit 41 of the user terminal 1 displays a care method image 71A showing a care method proposed to the user. In the example shown in FIG. 11, the care method image 71A displays a care method proposed to a user who has selected "itchiness" as a skin trouble symptom and "neck" as a symptom occurrence site. In the example shown in FIG. 11, a plurality of different preparations having the same efficacy are displayed in the care method image. The user can consult with a pharmacist about which preparation to select during a face-to-face consultation. In addition, the care method image 71A is provided with a box for checking whether or not to receive a monitoring service 99 provided after membership registration, and the user's checking of the box indicates that the user has consented to the provision of the service. The monitoring service 99 may be provided using, for example, an SNS such as LINE (registered trademark) as a care index measurement navigator.

[0121] In addition, the processing unit 14 may generate a care method image so that the user can know that the care method is currently being performed by the user when the care method currently being performed by the user is included in the extracted candidate care methods based on the current handling information 95 included in the user information (see FIG. 11). The care method image may also be presented to the pharmacist. By presenting such a care method image to the pharmacist, the pharmacist can consider in advance, for example, that the care method currently being performed by the user may not be suitable for the user's skin, or that it may be better to recommend a medical examination, together with other skin information such as skin images, before a face-to-face consultation, and can propose and advise a care method suitable for the user.

[0122] As shown in Fig. 12(A), a care method image 71B showing information on how to spend one day (24 hours) using the above care items is displayed on the display unit 41 of the user terminal 1. In Fig. 12(A), (1), (2) ... correspond to 1, 2 ... given to each care item in Fig. 11.

[0123] As shown in FIG. 12(A), the care method image 71B displays information including the timing of use of the care items proposed in FIG. 11, the amount of use of the care items, and points for using the care items (points to note when using the care items) as a care method. In the example shown in FIG. 12(A), a day is displayed in chronological order, such as morning, daytime / when going out, bathing, after bathing, and before sleep, and the type of care performed at each timing is displayed. The care method image 71B displaying the flow of care for one day can be viewed, for example, even during the period of performing the care method, and the user can check the care method by looking at the care method image 71B as necessary. In addition, by being able to check the flow of the care method for one day before purchasing a care item, the user can easily simulate the state of a day when the care method is actually performed, and can easily judge whether the care method is one that the user can perform.

[0124] The care method image 71C shown in FIG. 12(B) displays information on the flow after purchasing the skin care program, and a purchase button used when purchasing the skin care program. The care method image 71C presents that, in the flow after purchasing the skin care program, the user is first introduced to a pharmacist who will consult with the user about the care method to be performed when the skin care program is executed, and that the user will decide on the care method in a face-to-face consultation with the pharmacist and purchase a care item. Furthermore, the care method image 71C presents how the skin care program is executed for 28 days using the care method proposed by the server 10. In this embodiment, a predetermined execution period is set, such as the execution period of the care method being 28 days (about one month). In the example shown in FIG. 12(B), the processing unit 14 divides the above-mentioned care method execution period into a plurality of divided periods, and generates a care method image 71C including care goal information for each divided period as presentation information. The care method image 71C, which displays the flow of care for 28 days (about one month), can be viewed, for example, even during the care method execution period, and the user can check the overall flow of care, etc., by looking at the care method image 71C as necessary. In the example shown in FIG. 12(B), the 28 days (about one month) that is the care method execution period is divided into four, and each divided period is the first divided period, the first week (1st Week in the figure), the second divided period, the third divided period, the third divided period, and the fourth divided period. The care method start date is the first day, and the first to seventh days are the first week, the eighth to fourteenth days are the second week, the fifteenth to twenty-first days are the third week, and the twenty-second to twenty-eighth days are the fourth week.

[0125] In this way, the care method proposed to the user includes information on the type of care item to be used, information on the amount of the care item used, information on the timing of use of the care item, information on the frequency of use, information on precautions for using the care item, information on the goal and purpose of care for each divided period, information on the role of the care item in each divided period, etc. The care method image presented to the user is also provided to the pharmacist who will be the face-to-face consultation partner.

[0126] When the user who has examined the care method images 71A to 71C selects either the purchase button or the do not purchase button, the user terminal 1 transmits selection result information to the server 10. The processing unit 14 acquires a response (selection result) as to whether or not to purchase a skin care program (ST16).

[0127] Next, the processing unit 14 judges whether or not there is a purchase request based on the user's selection result (ST17). When the processing unit 14 judges that there is no purchase request (NO to ST17), the processing unit 14 ends the processing. On the other hand, when the processing unit 14 judges that there is a purchase request (YES to ST17), it assumes that a membership registration application has been made, performs a membership registration process for the user (ST18), and issues a user ID to the user. The processing unit 14 transmits information related to the payment of the skin care program purchase amount together with the user ID to the user terminal 1, and after confirming that the user has completed the payment, performs the processing from ST18 onwards. By confirming the membership registration process and the completion of the payment by the user, the server 10 can provide the user with a pharmacist introduction service 96, a schedule adjustment service 97, a care method suggestion service 98, and a monitoring service 99. Note that the care method proposed to the user after the purchase of the skin care program may be the care method proposed to the user before the purchase (content related to the care method images 71B and 71C) with further detailed information added thereto.

[0128] After completing the member registration, the processing unit 14 generates an image instructing the user to take a skin image including the symptom manifestation site as presentation information and transmits it to the user terminal 1. The user terminal 1 displays an image instructing the user to take a picture on the display unit 41 based on the received presentation information. FIG. 14 shows a photo check image 75 displayed on the display unit 41 of the user terminal 1, which includes a skin image 8 including a symptom manifestation site 60 photographed by a user or the like. When the button "Check with this photo" displayed on the photo check image 75 is selected by tapping or clicking, the skin image 8 is approved to be used as a check image. The user terminal 1 transmits the skin image 8 to the server 10 based on the user's selection input operation of the button "Check with this photo". The skin image 8 is manifestation site image information before the start of the care method, and is provided to the pharmacist as part of the user's skin information 91 before the face-to-face consultation between the user and the pharmacist. Note that the image examples of FIG. 14 and FIG. 19 described later show an example in which the user selects "redness" as a skin trouble symptom and selects "cheek" as a symptom manifestation site. 14 and 19, the "redness" of the skin is expressed by dots, and the difference in the degree of redness is expressed by the density of the dots. The higher the degree of redness (i.e., the more severe the symptoms), the denser the dots are shown, and the lower the degree of redness (i.e., the more mild the symptoms), the sparser the dots are shown.

[0129] The processing unit 14 acquires the skin image transmitted from the user terminal 1 (ST19). The processing unit 14 associates the user information obtained in the questionnaire, the user ID, the skin image, and the skin image acquisition date and time in the user information DB 153 for each user.

[0130] Next, the processing unit 14 acquires the pharmacist information 80 from the pharmacist information DB 154 prepared in advance (ST20).

[0131] Next, the processing unit 14 provisionally determines a pharmacist to be introduced to the user using the pharmacist information 80 and the user information 90 (ST100). The pharmacist provisional determination process in ST100 will be described below with reference to the flows in Figures 15 to 17. Note that the method of the pharmacist provisional determination process is not limited to the method described here.

[0132] 15, in the pharmacist tentative selection process, first, the processing unit 14 refers to the address of the affiliated pharmacy included in the pharmacist attribute information 84, and extracts pharmacies located in the same area as the area in which the user desires to have a face-to-face consultation, which is included in the desired area information 932 of the user information 90 (ST101). Next, the processing unit 14 refers to the pharmacist attribute information 84, and extracts all pharmacists who belong to the extracted pharmacies (ST102). Note that, although the description here assumes that one or more pharmacies are extracted, if no pharmacies are extracted, the user may be instructed to change the desired area.

[0133] Next, the processing unit 14 refers to the available skin trouble symptom information 81 included in the pharmacist information 80, and judges whether or not there is a pharmacist among the extracted pharmacists who can treat the skin trouble symptom of the user included in the symptom information 912 of the user information 90 (ST103). Specifically, it judges whether or not there is a pharmacist with a symptom handling capability evaluation value of 2 or 3, that is, a pharmacist who can treat the skin trouble symptom of the user. Note that here, an example will be described in which the user selects one skin trouble symptom in Q.01 of the questionnaire image 70A.

[0134] If the processing unit 14 determines that there is no available pharmacist (NO to ST103), it generates instruction information instructing the user to change the desired area and transmits it to the user terminal 1 (ST104). The user terminal 1 displays an image instructing the user to change the area on the display unit 41 based on the received instruction information. The user terminal 1 transmits the desired area information that has been changed and re-input by the user in accordance with the area change instruction image to the server 10. The processing unit 14 acquires the changed desired area information (ST105). Next, the process returns to ST101 and repeats the process.

[0135] On the other hand, when the processing unit 14 determines that there is a pharmacist available (YES to ST103), it refers to the available schedule information 83 included in the pharmacist information 80, and extracts from among the pharmacists who can treat the skin trouble symptoms, a pharmacist who is available for a face-to-face consultation on the desired schedule included in the desired schedule information 931 of the user information 90 (ST106).

[0136] Next, the processing unit 14 judges whether or not there are any extracted pharmacists (whether the number of extracted pharmacists is 1 or more) (ST107). If the processing unit 14 judges that there are no pharmacists (the number of extracted pharmacists is 0) (NO to ST107), it generates instruction information instructing a schedule change and transmits it to the user terminal 1 (ST108). The user terminal 1 displays an image instructing a schedule change on the display unit 41 based on the received instruction information. The user terminal 1 transmits the desired schedule information that has been changed and re-input by the user in accordance with the schedule change instruction image to the server 10. The processing unit 14 acquires the changed desired schedule information (ST109). Next, the process returns to ST106 and repeats the process.

[0137] When the processing section 14 determines that an extracted pharmacist is present (YES in ST107), it determines whether or not the user has a life task based on the life task information 92 included in the user information 90 (ST110).

[0138] When the processing unit 14 determines that there is no lifestyle problem (NO in ST110), as shown in FIG. 17, it determines whether or not there is a pharmacist with a symptom response capability evaluation value of 3 for the user's skin trouble symptoms among the pharmacists extracted in ST106 (ST130). When the processing unit 14 determines that there is a pharmacist with a symptom response capability evaluation value of 3 (YES in ST130), it provisionally decides that the pharmacist with the symptom response capability evaluation value of 3 is the pharmacist to be introduced to the user (ST131), and proceeds to ST22. When the processing unit 14 determines that there is no pharmacist with a symptom response capability evaluation value of 3 (NO in ST130), it provisionally decides that the pharmacist with the symptom response capability evaluation value of 2 is the pharmacist to be introduced to the user (ST132), ends the provisional decision process, and proceeds to ST22. One or more pharmacists are extracted.

[0139] When the processing unit 14 determines that there is a life task (YES in ST110), it determines whether or not there is a pharmacist whose symptom response capability evaluation value and problem response evaluation value are both 3 among the pharmacists extracted in ST106 (ST111), as shown in Fig. 16. Note that, here, an example in which the user has one life task will be described.

[0140] When the processing unit 14 determines that there is a pharmacist whose symptom response capability evaluation value and problem response evaluation value are both 3 (YES in ST111), it provisionally determines the pharmacist whose symptom response capability evaluation value and problem response evaluation value are both 3 as the pharmacist to be introduced to the user (ST112), ends the provisional determination process, and proceeds to ST22. One or more pharmacists are extracted.

[0141] When the processing unit 14 determines that there is no pharmacist whose symptom response capability evaluation value and problem response evaluation value are both 3 (NO to ST111), it determines whether or not there is a pharmacist whose symptom response capability evaluation value is 3 among the pharmacists extracted in ST106 (ST113).

[0142] When the processing unit 14 determines that there is a pharmacist with a symptom handling capability evaluation value of 3 (YES in ST113), it determines whether or not there is a pharmacist with a problem handling capability evaluation value of 2 among the pharmacists extracted in ST106 (ST114).

[0143] When the processing unit 14 determines that there is a pharmacist with a problem response evaluation value of 2 (YES to ST114), it provisionally determines the pharmacist with a symptom response capability evaluation value of 3 and a problem response evaluation value of 2 as the pharmacist to be introduced to the user (ST115), ends the provisional determination process, and proceeds to ST22. One or more pharmacists are extracted.

[0144] If the processing unit 14 determines that there is no pharmacist with a problem response evaluation value of 2 (NO to ST114), it provisionally determines a pharmacist with a symptom response capability evaluation value of 3 and a problem response evaluation value of 1 as a pharmacist to be introduced to the user (ST116), terminates the provisional determination process, and proceeds to ST22. One or more pharmacists are extracted.

[0145] When the processing unit 14 determines that there is no pharmacist with a symptom response capability evaluation value of 3 (NO in ST113), it determines whether or not there is a pharmacist with a problem response capability evaluation value of 3 among the pharmacists extracted in ST106 (ST117).

[0146] When the processing unit 14 determines that there is a pharmacist with a symptom response capability evaluation value of 3 (YES to ST117), it provisionally determines, from among the pharmacists extracted in ST106, a pharmacist with a symptom response capability evaluation value of 2 and a problem response evaluation value of 3 as the pharmacist to be introduced to the user (ST118), terminates the provisional determination process, and proceeds to ST22.

[0147] When the processing unit 14 determines that there is no pharmacist with a task capability evaluation value of 3 (NO in ST117), it determines whether there is a pharmacist with a task capability evaluation value of 2 (ST119).

[0148] When the processing unit 14 determines that there is a pharmacist with a symptom response capability evaluation value of 2 (YES to ST119), it provisionally determines, from among the pharmacists extracted in ST106, a pharmacist with a symptom response capability evaluation value of 2 and a problem response evaluation value of 2 as the pharmacist to be introduced to the user (ST120), terminates the provisional determination process, and proceeds to ST22.

[0149] When the processing unit 14 determines that there is no pharmacist with a problem-handling capability evaluation value of 2 (NO to ST119), it provisionally determines, from among the pharmacists extracted in ST106, a pharmacist with a symptom-handling evaluation value of 2 and a problem-handling evaluation value of 1 as a pharmacist to be introduced to the user (ST121), terminates the provisional determination process, and proceeds to ST22. Note that, if a configuration is made such that a pharmacist with both a symptom-handling evaluation value and a problem-handling evaluation value of 2 or more is provisionally determined, when the result is NO to ST114 or NO to ST119, the flow may return to ST104 or ST108 for processing.

[0150] In ST100, one or more pharmacists who can treat the user's skin trouble symptoms on the user's desired schedule are provisionally determined as consultation partners for the user (schedule adjustment services 86 and 97). Note that when provisionally determining a pharmacist in ST100, the user's request information may also be used to determine the pharmacist. Here, the following explanation assumes that multiple pharmacists have been provisionally determined in ST100.

[0151] In this way, in ST100, a pharmacist who has a higher degree of expertise in treating skin trouble symptoms and / or lifestyle issues can be provisionally determined. This makes it possible to introduce a pharmacist who is more suitable for the user to the user.

[0152] In this embodiment, the case where the user has one skin trouble symptom is taken as an example in the provisional decision of the pharmacist in ST100, but in the case where there are multiple skin trouble symptoms, the provisional decision of the pharmacist may be made using the average symptom response evaluation value corresponding to the user's skin trouble symptoms. Alternatively, when acquiring user information through a questionnaire, if multiple skin trouble symptoms are checked, the user may be asked to rank the skin trouble symptoms in order of their concern, and the provisional decision of the pharmacist may be made using the symptom response evaluation value corresponding to the one skin trouble symptom that the user is most concerned about.

[0153] In addition, in this embodiment, the case where there is one life task is taken as an example in the provisional selection of a pharmacist in ST100, but in the case of multiple life tasks, the provisional selection of a pharmacist may be made using the average value of the task-handling capability evaluation values ​​corresponding to the user's life tasks. Alternatively, when obtaining user information through a questionnaire, if multiple life tasks are checked, the user may be asked to rank the life tasks in order of their concern, and a provisional selection of a pharmacist may be made using the task-handling capability evaluation value corresponding to the one life task that is of most concern.

[0154] Returning to Fig. 13, the process from ST22 onwards will be described. In ST22, processing unit 14 generates presentation information to be presented to pharmacy terminal 20, and transmits it to pharmacy terminal 20. The presentation information is transmitted to all pharmacy terminals 20 installed in the pharmacies to which the provisionally selected pharmacist belongs.

[0155] The presented information transmitted to the pharmacy terminal 20 includes information (such as name) that can identify the pharmacist provisionally selected as the user's consultation partner, schedule information for the face-to-face consultation desired by the user, user information 90 including skin information 91, and the like (user information provision service 85). The presented information may also include the same information as the care method proposed to the user before purchase (care method proposal service 87). The presented information also includes a button to select whether the face-to-face consultation with the user is "possible" or "impossible." The provisionally selected pharmacist checks the image (presented information) transmitted to the pharmacy terminal 20 and displayed on the display unit 241, judges whether the face-to-face consultation is possible based on his / her own schedule, and also selects the possible button or the impossible button by referring to the user information, etc. as necessary. The selection result is transmitted from the pharmacy terminal 20 to the server 10.

[0156] Next, the processing unit 14 obtains the pharmacist's response from the pharmacy terminal 20 (ST23). The processing unit 14 determines the pharmacist who responded that they are available for face-to-face consultation with the user as the pharmacist to be introduced to the user (ST24). One or more pharmacists are introduced to the user. Here, if there are zero pharmacists to be introduced to the user, the processing unit 14 may transmit presentation information to the user terminal 1 including information that there is no pharmacist to be introduced and information instructing the user to change the settings of the desired area and / or desired schedule, and the tentative pharmacist determination process (ST100) may be performed again.

[0157] Next, the processing unit 14 generates presentation information including information related to the one or more pharmacists to be introduced and the face-to-face consultation schedule, and information such as the location and contact information of the pharmacy to which the pharmacist belongs, and transmits the information to the user terminal 1 (ST25). The user checks the image (presentation information) transmitted to the user terminal 1 and displayed on the display unit 41, selects one of the presented pharmacists and consultation schedules, and taps or clicks the decision button displayed on the image. As a result, answer information related to the pharmacist and consultation schedule selected by the user is transmitted to the server 10. The processing unit 14 acquires the answer from the user terminal 1 (ST26). With the answer, the pharmacist for face-to-face consultation and the face-to-face consultation schedule are finally decided.

[0158] The processing unit 14 generates presentation information informing the user that the face-to-face consultation date has been confirmed and that the matching between the user and the pharmacist has been confirmed, and transmits the information to the user terminal 1 and the pharmacy terminal 20 of the pharmacy to which the finally confirmed pharmacist belongs (ST27).

[0159] The presented information transmitted to the user terminal 1 in ST27 includes information such as confirmation of a face-to-face consultation with a pharmacist, confirmation of the date for the face-to-face consultation, pharmacist information about the decided pharmacist, and information related to the care method presented to the user before purchase (pharmacist introduction service 96, schedule adjustment service 97, care method suggestion service 98).

[0160] In ST27, the presented information sent to the pharmacy terminal 20 to which the pharmacist selected as the consultation partner belongs includes information that a face-to-face consultation with the user has been confirmed, that the date for the face-to-face consultation has been confirmed, user information 90, and the same information relating to the care method presented to the user before purchase (user information provision service 85, schedule adjustment service 86, care method suggestion service 87).

[0161] In ST27, the presentation information sent to the pharmacy terminal 20 to which the provisionally selected pharmacist other than the pharmacist selected as the consultation partner who responded that he or she is available belongs includes information informing the user that the face-to-face consultation with the user has been canceled.

[0162] Furthermore, the processing unit 14 may include, in addition to or instead of the care method proposed using the care method DB 152, information on other users having skin information 91 and / or life task information 92 similar to that of the user, which is extracted from the user information DB 153, in the presentation information transmitted to the pharmacy terminal 20 and the user terminal 1. The information on other users includes, for example, the care method performed by the other users, skin change information (monitoring information) due to the execution of the care method, impressions on the execution of the care method, and information on what is being done for the life tasks. The above-mentioned "similar" other users refer to other users who have at least one of the expression site information 911, symptom information 912, symptom degree information 914, and expression frequency information 915 included in the skin information 91, which is the same as the user, and typically have at least the same symptom information 912 as the user. The above-mentioned "similar" other users refer to other users who have listed at least one life task among one or more life tasks listed by the user in the life task information 92. The processing unit 14 may accumulate information on a plurality of users that are precedent cases, and provide the pharmacist and the user with information (information on other users) on care methods that have a high improvement effect among other users in similar circumstances to the user based on the information. The same applies to life tasks. In this way, information on other users may be provided as advice on care methods and / or life tasks based on precedent cases. Thereby, even if only pharmacists with a symptom response capability evaluation value of 2 and a task response capability evaluation value of 1 are extracted in ST121, the pharmacist can provide advice on life tasks to the user by referring to information on other users based on precedent cases presented by the server 10. The information stored in the care method DB may be generated based on precedent cases (information on a plurality of users who have executed a skin care program in the past), and may be updated from time to time based on the cases.

[0163] Next, the processing unit 14 links the user information 90, the care method proposed by the server 10, the determined face-to-face consultation schedule information, the determined pharmacist information for the face-to-face consultation, etc., for each user, and stores them in the user information DB 153. Also, the processing unit 14 links the determined face-to-face consultation schedule information, the user information of the user who will have the face-to-face consultation, the care method proposed by the server 10, etc., for each pharmacist, and stores them in the pharmacist information DB 154 (ST28).

[0164] As described above, by matching a user with a pharmacist, a pharmacist who can deal with the user's skin trouble symptoms can be introduced on the user's desired schedule. Furthermore, in this embodiment, the pharmacist to be introduced to the user is determined taking into account the pharmacist's expertise in dealing with skin trouble symptoms and / or lifestyle issues, so that a pharmacist who can provide the user with the information desired by the user and can give more suitable advice to the user can be introduced.

[0165] In addition, in the information processing system 100, the server 10 adjusts the face-to-face consultation on the date desired by the user while referring to the schedule of the pharmacist, so that the user and the pharmacist are not bothered by schedule adjustments, and the user can have a face-to-face consultation on the date desired by the user. In addition, since a pharmacist who can handle the user's skin trouble symptoms can be extracted as a face-to-face consultation partner, the user can save the trouble of looking at the pharmacist's profile and searching for a pharmacist suitable for the user. Furthermore, in this embodiment, a pharmacist who is more skilled at dealing with the user's skin trouble symptoms can be determined as a consultation partner. This allows the user to approach the skin care program with even more peace of mind, and even if questions or concerns arise during the execution of the skin care program, the user can feel at ease knowing that they can consult with a pharmacist at any time. Furthermore, in this embodiment, if the user has a life task, a pharmacist who is more skilled at the life task can be determined as a consultation partner, so the user's quality of life can be further improved.

[0166] (Face-to-face consultation before starting a skin care program) A face-to-face consultation between the user and the pharmacist is held on the determined consultation date, and the care items, etc. that the user will ultimately purchase are determined. In the face-to-face consultation, the pharmacist has knowledge of the user's skin information 91 and lifestyle problem information 92 in advance, so the user does not need to explain the state of his or her skin trouble or the troubles (lifestyle problems) associated with the skin trouble to the pharmacist in detail, and the face-to-face consultation can be carried out smoothly and efficiently. Since the pharmacist can obtain the skin information 91 of the user who will be consulted face-to-face as preliminary knowledge in advance, the pharmacist can prepare well in advance for the face-to-face consultation and can provide reliable advice suitable for the user. In addition, the pharmacist can use the information related to the care method proposed by the server 10 to directly check the site where the user's skin trouble symptoms appear during the face-to-face consultation, and can suggest a care item more suitable for the user while appropriately checking the user's lifestyle by hearing from the user, etc. In addition, the care method proposed by the server 10 is presented to both the user and the pharmacist in advance before the face-to-face consultation, so that the face-to-face consultation can be carried out with information on the care method shared, and efficient consultation is possible.

[0167] The care method proposed to the pharmacist from the server 10 via the pharmacy terminal 20 may include detailed information such as detailed ingredients, efficacy, and precautions for use of each care item in addition to the care method information proposed to the user. This allows the pharmacist to give appropriate advice to the user while checking the contents of the care item.

[0168] Information regarding the care items that were finally decided upon through face-to-face consultation between the user and the pharmacist and purchased by the user (final care method, purchase history information) is input by the pharmacist from the pharmacy terminal 20 and transmitted to the server 10. The processing unit 14 associates the information regarding the finally decided care items (purchase history information) and their purchase date information with each user, and stores them in the user information DB 153. By storing the purchase history information in this manner, the pharmacist can check in advance the care method being performed by the user before the second or subsequent face-to-face consultation between the user and the pharmacist.

[0169] [Just before and after starting a skin care program] When the processing unit 14 receives a request for provision of the monitoring service 99 from the user terminal 1 that has accessed the member site immediately before the start of the skin care program, the processing unit 14 generates presentation information instructing the user to take a skin image including the symptom manifestation site, and transmits the information to the user terminal 1. The user terminal 1 displays an image instructing the user to take a picture on the display unit 41 based on the received presentation information. For example, as shown in FIG. 14, a skin image 8a including a symptom manifestation site 60 photographed by a user or the like is displayed on the display unit 41. When the "Check with this photo" button is selected by tapping or clicking, the skin image 8a photographed by the user is approved to be used as the first-time photographed skin image. The user terminal 1 transmits the skin image 8a to the server 10 based on the user's selection input operation of the "Check with this photo" button. The skin image 8a is a skin image before the start of the care method (before the start of the skin care program), and is the "first-time photographed skin image."

[0170] The information processing method when acquiring the second or subsequent captured skin images related to the monitoring service 99 will be described with reference to the flow shown in FIG.

[0171] When a predetermined period of time has elapsed since the start of the skin care program, the processing unit 14 transmits a message to the user terminal 1 as part of the monitoring service 99, notifying the user that the scheduled date for acquiring a skin image (monitoring date) is approaching. The message is delivered using a mechanism such as email or push notification, or a similar mechanism. For example, the message may be sent to a LINE (registered trademark) account. The skin image is acquired in order to grasp the change in condition of the symptom manifestation site.

[0172] 18, the user who receives the message enters a user ID and password at the member site and logs in to the member site. When the processing unit 14 receives a request for provision of a monitoring service 99 from the user terminal 1, it obtains a previously obtained skin image from the user information DB 153 (ST30).

[0173] Next, the processing unit 14 transmits presentation information to the user terminal 1 to instruct the user to acquire a skin image including the symptom occurrence site 60, similar to the acquisition of the first-time captured skin image 8a. A skin image is acquired in the user terminal 1 based on the presentation information and transmitted to the server 10. The processing unit 14 acquires the captured skin image during monitoring (current skin image) (ST31). The processing unit 14 stores the captured skin image during monitoring together with the capture date and time in the user information DB 153 in association with the user.

[0174] The processing unit 14 generates presentation information (monitoring image) including a previously acquired skin image and a current skin image, for example, as shown in FIG. 19, and transmits it to the user terminal 1 (ST32) (monitoring service 99). The example shown in FIG. 19 is a monitoring image 72 presented to the user during the third monitoring. As shown in FIG. 19, in the monitoring image 72, a previously acquired first-time captured skin image 8a, a second-time captured skin image 8b acquired during the second monitoring, and a third-time skin image 8c (current skin image) acquired during the current third monitoring are displayed in chronological order. This allows the user to visually and intuitively grasp the change in the skin due to the execution of the skin care program. The monitoring image 72 is associated with the user and stored in the user information DB 153. The monitoring image 72 is configured so that the pharmacist who the user consults can also check it (monitoring information provision service 88).

[0175] In addition, in ST32, the processing unit 14 generates presentation information (questionnaire image) including questions regarding consultation with a pharmacist, for example, as shown in Figs. 20(A) and (B), and transmits it to the user terminal 1. The questionnaire images 73A and 73B shown in Figs. 20(A) and (B) display a question (Q.01) asking whether or not the user wishes to consult with a pharmacist, a question (Q.02) asking whether or not there is a desired pharmacist, a question (Q.03) asking the desired area for face-to-face consultation with a pharmacist, a question (Q.04) asking the desired date, and a question (Q.05) asking requests. The answers input by the user to the questionnaire images 73A and 73B are transmitted to the server 10. The processing unit 14 acquires answer result information (information on whether or not the user wishes to consult with a pharmacist, desired area information, desired date information, and request information) from the user terminal 1 (ST33).

[0176] Next, the processing unit 14 judges whether or not the user desires to consult with a pharmacist based on the answer result information (ST34). If the processing unit 14 judges that the user does not desire to consult with a pharmacist (NO in ST34), the processing unit 14 ends the processing. If the processing unit 14 judges that the user desires to consult with a pharmacist (YES in ST34), the processing unit 14 judges whether or not the user desires the previous pharmacist (ST35).

[0177] When the processing unit 14 determines that the previous pharmacist is desired (YES in ST35), it refers to the available schedule information of the pharmacist who handled the previous face-to-face consultation designated by the user, stored in the pharmacist information DB 154, and extracts a schedule when the face-to-face consultation between the user and the pharmacist is possible within the range of the desired schedule information included in the desired schedule information acquired in ST33. The processing unit 14 generates presentation information to be transmitted to the pharmacy terminal 20 installed in the pharmacy to which the pharmacist who handled the previous face-to-face consultation designated by the user belongs, and transmits it to the pharmacy terminal 20 (ST36). The presentation information includes information that the face-to-face consultation is the second or later regarding a skin care program, information about the pharmacist designated by the user, schedule information for the face-to-face consultation desired by the user, user information, purchase history information of the user, and information on the actual care method. The presentation information also includes a button for selecting whether the face-to-face consultation with the user is "possible" or "impossible". The pharmacist designated by the user checks the image (presentation information) transmitted to pharmacy terminal 20 and displayed on display unit 241, judges whether or not a face-to-face consultation is possible based on his / her own schedule, and selects a possible button or an impossible button. The result of the selection is transmitted from pharmacy terminal 20 to server 10.

[0178] Next, the processing unit 14 obtains the pharmacist's response from the pharmacy terminal 20 (ST37). The processing unit 14 determines the date for which the pharmacist has determined that face-to-face consultation is possible as the date for the face-to-face consultation between the user and the pharmacist (ST38). If there are multiple date candidates, the date that is ranked higher in the user's desired date candidate is determined as the date for the face-to-face consultation between the user and the pharmacist.

[0179] Next, the processing unit 14 notifies the user that the consultation schedule has been finalized, generates presentation information indicating the finalized schedule information (date, time zone), and transmits it to the user terminal 1 and the pharmacy terminal 20 (ST39) (schedule adjustment services 86 and 97). The processing unit 14 links the finalized face-to-face consultation schedule information and the pharmacist information (e.g., pharmacist ID) of the pharmacist who will be the consultation partner for each user, and stores them in the user information DB 153. The processing unit 14 links the finalized face-to-face consultation schedule information and the user information (e.g., user ID) of the user who will have the face-to-face consultation for each pharmacist, and stores them in the pharmacist information DB 154 (ST40).

[0180] As shown in FIG. 18, if the answer to Q.02 of the questionnaire image 73A in FIG. 20(A) is "another pharmacist preferred" or "anyone will do", the processing unit 14 determines that the previous pharmacist is not preferred (NO to ST35) and proceeds to ST20. The steps after ST20 (ST20, ST100, ST22 to ST27) are basically the same as the steps described with reference to FIG. 13 above (schedule adjustment services 86 and 97, user information provision service 85, pharmacist introduction service 96). However, if "another pharmacist preferred" is selected in Q.02 of the questionnaire image 73A, the processing unit 14 executes the steps after ST20 except for the previous pharmacist. Also, if "anyone will do" is selected in Q.02 of the questionnaire image 73A, the steps after ST20 are the same as the steps described with reference to FIG. 13 above. Following ST27, the processing unit 14 links the user information 90, the determined face-to-face consultation schedule information, and the determined pharmacist information for the face-to-face consultation for each user, and stores them in the user information DB 153. The processing unit 14 also links the determined face-to-face consultation schedule information and the determined user information for the face-to-face consultation for each pharmacist, and stores them in the pharmacist information DB 154 (ST40).

[0181] As described above, in this embodiment, while the skin care program is being executed, the user is provided with the monitoring service 99, the pharmacist introduction service 96, and the schedule adjustment service 97. In addition, the user information provision service 85, the schedule adjustment service 86, and the monitoring information provision service 88 are provided to the pharmacist.

[0182] In this way, in addition to the face-to-face consultation with a pharmacist before purchasing the skin care program (first face-to-face consultation), an opportunity for face-to-face consultation with a pharmacist may be provided while the skin care program is being implemented. In this embodiment, for the second or subsequent face-to-face consultation, the user can request a different pharmacist from the first pharmacist. Therefore, even if the user feels that he or she does not get along with the pharmacist who was in charge of the first face-to-face consultation, the user can have another pharmacist in charge of the next or subsequent face-to-face consultation, so that the user can continue the skin care program without stress. In addition, for a user who does not mind which pharmacist is in charge, the user's schedule is given priority and a pharmacist to consult with can be selected more reliably, which is convenient. In addition, since the server 10 provides the user information in advance, even if the user is a second or subsequent face-to-face consultation user who has never been in charge of the pharmacist before, the pharmacist can give appropriate advice to the user. In addition, even if the user changes pharmacists, the user does not need to explain in detail his or her own skin condition or the care method currently being performed, so that efficient consultation is possible.

[0183] <Other> The following describes modified examples.

[0184] [Variation 1] In the above embodiment, only one server 10 is shown, but the processes executed by the server 10 may be distributed and executed by a plurality of servers. For example, among the pharmacist extraction process, the care method determination process, the monitoring process, and the presentation information generation process performed by the processing unit 14, some of the processes and the other processes may be executed by different servers.

[0185] In addition, in the above-described embodiment, an example was given in which one server 10 has a processing unit 14 and a memory unit 15, but as in the information processing system 100A shown in FIG. 21, the server 10A having the processing unit 14 and the data server 15A having various databases such as a care method DB152, a user information DB153, and a pharmacist information DB154 may be separate servers.

[0186] In addition, each database may be managed by a separate server. In particular, it is preferable that the care method DB 152 referred to by the processing unit 14 is realized by a plurality of individual servers under the management of a plurality of companies that provide the care items.

[0187] [Variation 2] In the above embodiment, the processing unit 14 may obtain current treatment information 95 including consultation information indicating whether the user has visited a medical institution for a skin trouble symptom, and generate presentation information recommending the user to visit a medical institution according to the user's skin information 91 and the treatment information 95. This can give the user an opportunity to visit a medical institution when the user has difficulty in determining whether the skin trouble symptom requires a visit to a medical institution, and as a result, it is possible to provide a care method more suitable for the user. In addition, this also allows the pharmacist to know in advance whether the skin trouble is recurring and cannot be dealt with by visiting a medical institution.

[0188] [Variation 3] In the above embodiment, an example was given in which a pharmacist to be consulted and a schedule adjustment with the pharmacist were performed using the user's desired area information and desired schedule information, but the user may be configured to be able to specify a pharmacy to consult with. In this case, a question for answering the name of a desired pharmacy is provided in a questionnaire image for acquiring user information. When performing a tentative pharmacist determination process, the processing unit 14 refers to the pharmacist information DB 154 based on the user's desired pharmacy information, extracts all registered pharmacists belonging to the specified pharmacy, and performs substantially the same process as the process after ST103 shown in FIG. 15 to FIG. 17. However, if there is no pharmacist who can treat the skin trouble symptom in ST103 (NO to ST103), the processing unit 14 may generate presentation information to notify the user that there is no pharmacist who can treat the specified pharmacy and to instruct the user to select another pharmacy or select a desired area, and transmit the presentation information to the user terminal 1.

[0189] In this way, by allowing a user to specify a pharmacy, the user can have a face-to-face consultation with a pharmacist at a pharmacy that the user normally uses or a pharmacy that is easily accessible from the user's home, etc., which is very convenient.

[0190] [Variation 4] In the above-described embodiment, an example was given in which the user is suggested to have a face-to-face consultation with a pharmacist at the time when skin images for monitoring are obtained during the execution of the care program, but the system may be configured so that the user can have a face-to-face consultation with a pharmacist at any time of their choosing.

[0191] [Variation 5] In the above embodiment, in the pharmacist provisional decision process of ST100, the symptom response capability evaluation value is configured to take precedence over the life task response capability evaluation value, but this is not limited. For example, in a range of symptom response evaluation value of 2 or more, a pharmacist with a higher life task response evaluation value may be provisionally decided with higher priority. In addition, the user may be allowed to select whether to give priority to the symptom response capability evaluation value or the life task response capability evaluation value. For example, if a user wants to consult with a pharmacist who has a high level of expertise in life tasks and a level of expertise above average (capable of handling) in the user's skin trouble symptoms because the user wants to focus on life tasks, the user can select to have a pharmacist decided with higher priority given to the life task response capability evaluation value. [Explanation of symbols]

[0192] 14... Processing section 81...Skin trouble symptoms that can be treated 83...Available dates and times 91…Skin information 912…Symptom information 100...Information processing systems 931…desired schedule information P1, P2, P3, P4, P5...Pharmacist (Qualified to sell pharmaceutical products)

Claims

1. Acquire skin information including symptom information indicating a skin trouble symptom of a user and desired schedule information indicating a desired schedule of the user for the user to consult with a pharmaceutical sales qualified person about the skin trouble symptom; Acquire previously prepared schedule information on the availability of each of a plurality of drug sales qualified persons and available skin trouble symptom information regarding the available skin trouble symptoms that each of the plurality of drug sales qualified persons can treat, Based on the available schedule information and the available skin trouble symptom information, a qualified pharmaceutical salesperson capable of dealing with the skin trouble symptom of the user included in the symptom information on the desired schedule included in the desired schedule information is extracted from the plurality of qualified pharmaceutical salespersons as a qualified pharmaceutical salesperson to be introduced to the user. Processing section An information processing system comprising:

2. The processing unit generates presentation information indicating the skin information to be presented to the extracted pharmaceutical sales qualified person. The information processing system according to claim 1 .

3. The said pharmaceutical sales qualified person is a pharmacist 3. The information processing system according to claim 1 or 2.

4. The processing unit includes: extracting information about other users having skin trouble symptoms similar to those of the user from information about skin troubles of other users prepared in advance based on the skin information; Generate presentation information indicating information about the extracted pharmaceutical sales qualified persons and the other users to be provided to the user. The information processing system according to any one of claims 1 to 3.

5. In the information processing device, acquiring skin information including symptom information indicating a skin trouble symptom of a user and desired schedule information indicating a desired schedule of the user for the user to consult with a pharmaceutical sales qualified person about the skin trouble symptom; A step of acquiring previously prepared schedule information of each of a plurality of drug sales qualified persons and information on skin trouble symptoms that each of the plurality of drug sales qualified persons can treat; A step of extracting, from among the plurality of qualified pharmaceutical sales persons, a qualified pharmaceutical sales person capable of dealing with the skin trouble symptom of the user included in the symptom information on the desired schedule included in the desired schedule information, as a qualified pharmaceutical sales person to be introduced to the user, based on the available schedule information and the available skin trouble symptom information. A program for executing the above.

Images